Important life science current events from this week include Mayo Clinic helicopter crash, ten movies that portray pharmaceutical companies negatively, and an influential UW chairman takes heat for royalties and conflicts-of-interest with Medtronic.
Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com. Now here's the best of what YOU had to say.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Some opioid painkillers used by cancer patients are governed by U.S. Food and Drug Administration plans to manage possible health risks. The FDA is changing how it manages these drugs and these changes should help Raleigh, North Carolina company BioDelivery Sciences International (NASDAQ:BDSI). Here’s how. BDSI’s product Onsolis delivers the painkiller fentanyl through a small […]
Mayo Clinic procurement technician David Hines and cardiovascular surgeon Dr. Louis Bonilla were doing what they do every day — procuring an organ to save a patient’s life — when they lost their own lives in an early morning helicopter crash on Monday, says one colleague in tribute videos posted on the hospital’s blog. Because […]
In the midst of a struggling economy, there is one sector that is rapidly growing – booming, in fact. That sector is health care. Just as the baby boomers flooded the market with a demand for toys and diapers in the 1950s, so are they now flooding the market with a need for increased health […]
Celator Pharmaceuticals, a drug development company, is raising $5 million as its drug therapy for acute myeloid leukemia moves through phase 2 clinical trials. In its latest financing round, the company, which has offices in Princeton, New Jersey and Vancouver, British Columbia, has raised $2.57 million of its $5 million target through equity, options and […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Chelsea Therapeutics (NASDAQ:CHTP) is preparing for the launch of its first product — a drug for Parkinson’s disease patients — and the company plans to arm itself with nearly $20 million to do it. Chelsea aims to raise up to $19.7 million through a stock offering of more than 65 million shares, according to an […]
Current medical news from today, including Emergent BioSciences rebounds after Abbott pulls the plug on cancer drug partnership, searching for a cure for the hangover, and Avastin stabilizes ovarian cancer tumors in studies.
Healthcare doesn’t do “memes” — at least not as much as the tech industry does. But 2011 showed that is changing. Amid the tidal wave-sized trends like healthcare reform, innovation in the life sciences and healthcare has started to take to the web. Now more than ever, concepts that will change healthcare forever were starting […]
New York City has long been home to the big, brawny business monolith. From Wall Street firms like Goldman Sachs to huge media empires to CBS and Time-Warner, the Fortune 500 has regularly taken a big bite out of the Big Apple. But at the other end of the dial, small businesses — at least […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Why haven’t you seen more health IT companies accepted into DreamIt Ventures East Coast accelerators? DreamIt doesn’t know where to find them. “Health IT is interesting to us, but it’s never been part of our proactive recruiting strategy because we do not know where to source them,” said managing partner Kerry Rupp. “We do the […]
Hospira (NYSE:HSP) completed a two-year “restructuring and optimization plan” this year that the company expressly stated would increase shareholder value by generating annualized savings between $110 million and $140 million. But now the company faces a phalanx of angry shareholders claiming the company did not disclose the extent of problems at a North Carolina plant […]
Diagnostic test maker Meridian Bioscience‘s (NYSE:VIVO) Chief Executive Jack Kraeutler received a 3 percent increase in compensation this year to $843,000. Here’s how Kraeutler’s 2011 compensation breaks down, according to a recent regulatory filing: $546,000 in base salary; $228,000 in stock awards and $69,000 in “other” compensation, which includes retirement contributions, auto allowance and financial […]
Synthes is back in court, this time as the plaintiff in a lawsuit against Stryker Corp. (NYSE: SYK) accusing the Michigan-based medical device company of trying to obtain “an improper competitive advantage.” The complaint, filed in federal court in Philadelphia, also singled out three former sales staff from Synthes’ San Francisco sales unit who resigned from […]
Drug discovery startup NovaTarg is ramping up preclinical research in preparation of an expected investigational new drug application filing for the company’s first drug candidate — a new hepatitis C treatment . The Research Triangle Park, North Carolina-based company now has a $30,000 loan from the North Carolina Biotechnology Center to help its efforts. The […]